Back
PubMed - Biomedical Research Literature Database
governmentPubMed Central(peer-reviewed)·pubmed.ncbi.nlm.nih.gov/
Credibility Rating
4/5
High(4)High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: PubMed Central
PubMed is a general biomedical literature database; its relevance to AI safety is indirect, primarily as a source for empirical studies on human-AI interaction, automation effects, cognitive science, and related behavioral research.
Metadata
Importance: 30/100homepagereference
Summary
PubMed is the primary public database for biomedical and life sciences literature, maintained by the National Library of Medicine. It indexes millions of citations and abstracts from peer-reviewed journals, serving as a gateway to scientific research across medicine, biology, and related fields.
Key Points
- •Largest freely accessible database of biomedical literature with millions of indexed citations and abstracts
- •Maintained by the U.S. National Library of Medicine, ensuring reliability and comprehensive coverage
- •Relevant to AI safety researchers seeking peer-reviewed studies on human factors, cognitive science, and automation effects
- •Useful for finding empirical research on topics like skill degradation, human-AI interaction, and automation bias
- •Provides access to neuroscience and psychology research that informs alignment and interpretability work
Review
PubMed serves as a critical infrastructure for scientific research, offering an extensive repository of biomedical literature that encompasses citations from MEDLINE, life science journals, and online books. The platform not only provides access to millions of research citations but also continuously evolves its technological capabilities, with recent updates focusing on improved search tools, reference rendering, and user experience enhancements. The platform's significance extends beyond mere citation listing, as it provides links to full-text content, enables advanced searching techniques, and supports researchers through features like clinical queries, citation matching, and API access. Its ongoing improvements, such as synchronizing FTP data with website content and reintroducing customizable email features, demonstrate a commitment to supporting the scientific community's research and information discovery needs.
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| AI-Induced Expertise Atrophy | Risk | 65.0 |
Cached Content Preview
HTTP 200Fetched Apr 9, 20264 KB
PubMed
This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Clipboard, Search History, and several other advanced features are temporarily unavailable.
Skip to main page content
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Access keys
NCBI Homepage
MyNCBI Homepage
Main Content
Main Navigation
Home Page
Search:
Search
Advanced
Clipboard
PubMed® comprises more than 40 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full text content from PubMed Central and publisher web sites.
Learn
About PubMed
FAQs & User Guide
Finding Full Text
Find
Advanced Search
Clinical Queries
Single Citation Matcher
Download
E-utilities API
FTP
Batch Citation Matcher
Explore
MeSH Database
Journals
Trending Articles
PubMed records with recent increases in activity
Regulatory mechanism of miR-525-5p in over-invasion of trophoblast.
Zhang M, et al.
J Obstet Gynaecol Res. 2021.
PMID: 33258220
Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Meningitis & Antimicrobial Resistance Collaborators.
Lancet Neurol. 2026.
PMID: 41911930
Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial.
Dent R, et al.
Ann Oncol. 2026.
PMID: 41937088
GLP-1 Receptor Agonists.
Rosen CJ, et al.
N Engl J Med. 2026.
PMID: 41931049
Review.
Global burden of cancer in children and adolescents aged 0-19 years, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Childhood Cancer Collaborators.
Lancet. 2026.
PMID: 41936367
See more trending articles
... (truncated, 4 KB total)Resource ID:
689a9ff80da2437f | Stable ID: sid_7rQd3oqebu